课题基金 / 基金详情

INHIBITION OF GASTRIC ACID SECRETION BY INTRAVENOUS PANTOPRAZOLE IN ZES PATIENTS

INHIBITION OF GASTRIC ACID SECRETION BY INTRAVENOUS PANTOPRAZOLE IN ZES PATIENTS
静脉注射泮托拉唑对 ZES 患者胃酸分泌的抑制作用
批准号：
6265329
负责人：
JOSEPH R PISEGNA
金额：
$0.19万
依托单位：
UNIVERSITY OF CALIFORNIA LOS ANGELES
依托单位国家：
美国
项目类别：
财政年份：
1998
资助国家：
美国
项目状态：
已结题
起止时间：
1998-12-01 至 1999-11-30
来源：
https://reporter.nih.gov/project-details/6265329
关键词：
Zollinger Ellison syndrome antineoplastics clinical research clinical trial phase I drug adverse effect drug screening /evaluation gastric acid gastrointestinal agents human subject human therapy evaluation intravenous administration neoplasm /cancer chemotherapy neuropeptides secretion vasoactive intestinal peptide

项目摘要

项目成果

JOSEPH R PISEGNA的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Pituitary adenylate cyclase-activating polypeptide(PACAP), a neuropeptide belonging to the vasoactive intestinal peptide(VIP)/secretin/glucagon family of peptides, interacts with a distinct high-affinity receptor (type I receptor) on a number of tissues.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ShEEP Request for Acquisition a 10x Genomics Single Cell RNA Sequencer
CMA: Cancer Stem Cells in the Pathogenesis and Treatment of Colorectal Cancer
CMA: Cancer Stem Cells in the Pathogenesis and Treatment of Colorectal Cancer
CMA: Cancer Stem Cells in the Pathogenesis and Treatment of Colorectal Cancer
海外基金